Dabigatran and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Dabigatran and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran Etexilate
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabigatran-Signifor (Pasireotide Injection)
- Dabigatran-Signifor Injection
- Dabigatran-Signifor LAR
- Dabigatran-Signifor LAR Injection
- Dabigatran-Siklos
- Dabigatran-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Dabigatran Etexilate
- Signifor (Pasireotide Extended-Release Injection)-Dabigatran Etexilate Mesylate
- Signifor (Pasireotide Extended-Release Injection)-Dabrafenib
- Signifor (Pasireotide Extended-Release Injection)-Dabrafenib Mesylate
- Signifor (Pasireotide Extended-Release Injection)-Dacarbazine
- Signifor (Pasireotide Extended-Release Injection)-Dacarbazine Intravenous, Injection